A Phase II Trial of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II Trial of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Published:2020-03 Issue:3 Volume:26 Page:S188
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Al Malki Monzr M.,Tsai Ni-Chun,Palmer Joycelynne,Mokhtari Sally,Cao Thai,Ali Haris,Salhotra Amandeep,Arslan Shukaib,Aldoss Ibrahim,Karras Nicole,Zain Jasmine,Khaled Samer K.,Stein Anthony S.,Snyder David S.,Marcucci Guido,Forman Stephen J.,Nademanee Auayporn,Nakamura Ryotaro

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens;Bone Marrow Transplantation;2021-11-20

2. National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide;Journal of Clinical Oncology;2021-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP